Illumina Whole-Genome Sequencing Uncovers Genetic Signals Behind Common Diseases
Reuters
Nov 13, 2025
<a href="https://laohu8.com/S/ILMN">Illumina</a> Whole-Genome Sequencing Uncovers Genetic Signals Behind Common Diseases
Illumina Inc. has announced new scientific research results published in Nature, demonstrating the significant advantages of whole-genome sequencing $(WGS)$ in capturing the genetic basis of complex human diseases and traits. The study, conducted in collaboration with The University of Queensland, showed that Illumina's WGS, combined with DRAGEN variant calling and advanced AI tools, was able to capture nearly 90% of the genetic signal underlying 34 diseases and traits. This research addresses the longstanding "missing heritability" problem, revealing rare genetic variants that explain much of the heritability previously unaccounted for in common diseases such as those related to blood pressure and cholesterol. The results have already been presented through the publication in Nature.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Illumina Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA22068) on November 12, 2025, and is solely responsible for the information contained therein.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.